Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
http://www.nytimes.com/2013/10/26/business/tentative-approval-for-faster-acting-hepatitis-c-drug.html
Advisers to the Food and Drug Administration unanimously voted in favor of a hepatitis C drug from Gilead Sciences. All 15 members of the agency’s panel of virus experts voted to recommend approval of Gilead’s pill, sofosbuvir, to treat several forms of the disease, which afflicts more than three million people in the United States. The agency is not required to adhere to the group’s advice, though it often does. Current treatments can take up to a year of therapy and cure only about three out of four patients. Gilead’s daily pill can cure up to 90 percent of patients infected with the most common form of the virus in just 12 weeks. Gilead, based in Foster City, Calif., is one of a half-dozen companies racing to develop more effective treatments for hepatitis C. The agency is expected to make a decision on the drug by Dec. 8.
http://www.nytimes.com/2013/10/26/business/tentative-approval-for-faster-acting-hepatitis-c-drug.html
Advisers to the Food and Drug Administration unanimously voted in favor of a hepatitis C drug from Gilead Sciences. All 15 members of the agency’s panel of virus experts voted to recommend approval of Gilead’s pill, sofosbuvir, to treat several forms of the disease, which afflicts more than three million people in the United States. The agency is not required to adhere to the group’s advice, though it often does. Current treatments can take up to a year of therapy and cure only about three out of four patients. Gilead’s daily pill can cure up to 90 percent of patients infected with the most common form of the virus in just 12 weeks. Gilead, based in Foster City, Calif., is one of a half-dozen companies racing to develop more effective treatments for hepatitis C. The agency is expected to make a decision on the drug by Dec. 8.
Ok thanks rearden !
Please make sure that we have enough fridges for Prosseco and other drinks .
We were talking about $500 a share before the SPT
Are we talking now $1500?
And if that is the case are we going to have more SPT??
GOOG didn't do it.
On the way to Hawaii?
You are so spiritual !
You said 3 ?
I said 20!
FN
With the facilities finished by December ? I don't think so!
FN
I know, just having fun!
Before it would have taken a day to gain or lose 20 senses.
Now it takes just a second!
It look like a ping pong game!!
I meant 20 mn !
The stock could go at $10.00 or $20.00 in 2 mn !
Now we need to celebrate!!
We are on TV!!!!
And you are missing my point:
I agree with everything you are saying, this is no news for me!
I am certain that NNVC will deliver the data in black & white to the FDA!
That why I don't see any reason why the FDA would not pass NNVC!
FN
FZ
It could be an idea to take a picture next time and post it here!
So we can have a little celebration!!
Thanks for sharing!
FN FZ
It is not (or will not be anyway) be a question of political maneuvering IF the data are there in black & white.
I hear you.
But if NNVC proves that the drugs have no dangers to human beings,
I do not see why the FDA would not approve them.
Problem is - 'we' don't have to be convinced by the TOX testing. The FDA has to be convinced.
This is great news.
For me, this demonstrated that "FluCide" is not toxic.
This is a very important beginning for human trials.
It is clear that investors who do not really know NNVC are only there to play on the Exchange.
FN
in 45 mn
Don't forget our hike weedie!!!!
Thank you Weedie for the compliment !
And yes I keep my "chairs"
FORZA NANO!!!!!!!!!!!!!!
I do like Tyrolean Knickers.
It's getting there.
Next year: $70.00 ?
Hi Weedie!
Yes to $10.00
If you hate NNVC that much, can you explain why are you on this board?
NNVC 5.1189 (D) +0.1989 [+4.04%]
That make sense.
Not yet !
But that meeting will be the 2nd .
The 1 st. one was in January.
I will keep you informed
FN
R-1-K
I paste your questions to Dr Seymour!
Here are his answers:
These are complex questions
I think that I'll save them for our annual meeting
If we have good Phase I safety data, I believe that physicians can request the drug for compassionate use. If all goes well, that could happen sometime early during the 2014-15 flu season.
I need to research the question more fully when I'm back
Eugene Seymour, MD MPH
Chief Executive Officer
NanoViricides, Inc
310-486-5677
He is such a spoofer !!
But I think that the stock will be up by the end of the year.
I never trade NNVC. I will when the company will have there 9 viruses on the Market.
I would be to frustrated with myself if I started to play with it.
FN
Those ups and downs from the stock are crazy!
No idea in wich direction it will go at the closing of the day!
excellent tox data would get a large increase in SP regardless of what state the market is in
Wow! You got us Dave!
So why are you asking that question?
Google him.
That's a Bizzy number!